Real-time enrollment status for this idiopathic inflammatory myopathies clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 12:07 PM UTC
| NCT Number | NCT06698796 |
| Recruiting Status | Recruiting |
| Condition | Idiopathic Inflammatory Myopathies |
| Phase | Clinical Trial |
| Target Enrollment | 211 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Pfizer |
| Last Updated on CT.gov | August 15, 2025 (Aug 15, 2025) |
As of March 2, 2026: Clinical trial NCT06698796 is currently recruiting participants. This clinical trial study for idiopathic inflammatory myopathies is actively seeking new participants at 2 locations across the United States. The study is sponsored by Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06698796 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06698796 was last updated Aug 15, 2025 (August 15, 2025). HelloStudys verifies this status automatically.